Back to Search
Start Over
Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
- Source :
-
Archives of neurology [Arch Neurol] 2007 Sep; Vol. 64 (9), pp. 1306-11. - Publication Year :
- 2007
-
Abstract
- Background: Memory declines more rapidly with age in apolipoprotein E (APOE) epsilon4 carriers than in APOE epsilon4 noncarriers, and APOE epsilon4 homozygotes' cognitive performances correlate with stressors. These changes could represent presymptomatic disease in some, despite their youth.<br />Objective: To show that presymptomatic APOE epsilon4 homozygotes experience greater psychometric decline at a younger age than APOE epsilon4 heterozygotes and noncarriers before the diagnosis of mild cognitive impairment (MCI) and Alzheimer disease (AD).<br />Design: Prospective observational study<br />Setting: Academic medical center.<br />Participants: A total of 43 APOE epsilon4 homozygotes, 59 APOE epsilon4 heterozygotes, and 112 APOE epsilon4 noncarriers aged 50 to 69 years were cognitively healthy and matched at entry according to age, educational level, and sex.<br />Intervention: Neuropsychological battery given every 2 years.<br />Main Outcome Measures: Predefined test and cognitive domain decline criteria applied to consecutive epochs.<br />Results: Of 214 participants, 48 showed no decline on any test, 126 showed decline on only 1 test in 1 or more domains, and 40 showed decline on 2 or more tests in 1 or more domains. Cognitive domain decline occurred in 4 of 10 APOE epsilon4 homozygotes 60 years and older at entry (40.0%) compared with 5 of 66 APOE epsilon4 heterozygotes and noncarriers (7.6%) (P = .02) and was more predictive of subsequent decline than nondomain decline (17 of 24 [70.8%] vs 29 of 70 [41.4%]; P = .01). Decline on any memory test was predictive of further decline (P < .001), as was memory domain decline (P = .006) in all genetic subgroups. Seven participants developed MCI (in 6) or AD (in 1), of whom 5 were APOE epsilon4 homozygotes (P = .008). Retrospective comparison showed that those who experienced multidomain, memory, and language domain decline had lower spatial and memory scores at entry than those who experienced no decline.<br />Conclusions: APOE epsilon4 homozygotes in their 60s have higher rates of cognitive domain decline than APOE epsilon4 heterozygotes or noncarriers before the diagnosis of MCI and AD, thus confirming and characterizing the existence of a pre-MCI state in this genetic subset.
- Subjects :
- Aged
Aging physiology
Alleles
Female
Heterozygote
Homozygote
Humans
Intelligence Tests
Language Tests
Male
Mental Disorders psychology
Mental Recall physiology
Middle Aged
Neuropsychological Tests
Psychiatric Status Rating Scales
Psychomotor Performance physiology
Risk
Wechsler Scales
Apolipoprotein E4 genetics
Cognition physiology
Cognition Disorders genetics
Cognition Disorders psychology
Subjects
Details
- Language :
- English
- ISSN :
- 0003-9942
- Volume :
- 64
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Archives of neurology
- Publication Type :
- Academic Journal
- Accession number :
- 17846270
- Full Text :
- https://doi.org/10.1001/archneur.64.9.1306